During	IN
the	DT
race	NN
to	TO
develop	VB
an	DT
oral	JJ
polio	NN
vaccine	NN
several	JJ
large	JJ
scale	NN
human	JJ
trials	NNS
were	VBD
undertaken	VBN
.	.

In	IN
Africa	NNP
,	,
the	DT
vaccines	NNS
were	VBD
administered	VBN
to	IN
roughly	RB
one	CD
million	CD
people	NNS
in	IN
the	DT
Belgian	JJ
territories	NNS
,	,
now	RB
the	DT
Democratic	NNP
Republic	NNP
of	IN
the	DT
Congo	NNP
,	,
Rwanda	NNP
and	CC
Burundi	NNP
.	.

However	RB
,	,
recent	JJ
opposition	NN
to	IN
vaccination	NN
campaigns	NNS
has	VBZ
evolved	VBN
,	,
often	RB
relating	VBG
to	IN
fears	NNS
that	IN
the	DT
vaccine	NN
might	MD
induce	VB
sterility	NN
.	.

The	DT
disease	NN
has	VBZ
since	IN
resurged	VBN
in	IN
Nigeria	NNP
and	CC
in	IN
several	JJ
other	JJ
African	JJ
nations	NNS
,	,
which	WDT
epidemiologists	VBZ
cite	VBP
is	VBZ
due	JJ
to	IN
refusals	NNS
by	IN
certain	JJ
local	JJ
populations	NNS
to	TO
allow	VB
their	PRP$
children	NNS
to	TO
receive	VB
the	DT
polio	NN
vaccine	NN
.	.

